Researchers identify a treatment for a rare bone loss disorder that might also lead to help for aging brittle bones
A possible ‘first-line’ treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Hajdu-Cheney syndrome is a rare genetic disease that leads to severe osteoporosis and developmental defects, including the reabsorption of bones in the hands and feet. The disease is associated with mutations in a particular gene, called NOTCH2, which codes for proteins involved with bone maintenance. The NOTCH2 proteins usually help balance destruction and construction essential for bone maintenance and repair. Mutations associated with Hajdu-Cheney syndrome upset that balance, but the exact mechanisms causing bone resorption have not been well understood.
Now, through a series of detailed tests, molecular biologist Hiroyuki Inuzuka and his colleagues have worked out the specific molecular pathway that results in Hajdu-Cheney syndrome.
They found that this particular NOTCH2 mutation does not maintain normal NOTCH2 protein abundance, with the help of another protein, called FBW7. To discover this, the researchers knocked out the gene for Fbw7 in the bones of mice. Without the gene and resulting protein, the mice had severe osteoporosis, much like people with Hajdu-Cheney syndrome — indicating that FBW7 is the primary regulator of this system.
They further determined that in humans with Hajdu-Cheney syndrome, the FBW7 protein was unable to bind to NOTCH2 proteins because the binding spot is missing in osteoclasts. This mutation allows the osteoclasts to over-operate, breaking down too much bone tissue.
The researchers were able to reverse bone loss in the knock-out mice with the elevated NOTCH2 by giving them a medication that blocks osteoclast formation. They tried several different treatments, including a chemical compound called DAPT that was particularly effective. DAPT has been shown to help with osteoarthritis by inhibiting function of NOTCH proteins in other studies. Using DAPT as well as Zoledronic acid, a common medication for osteoporosis, “may become a first-line treatment for Hadju-Cheney syndrome,” the researchers conclude in their study.
“By clearly identifying the relationship between FBW7 and NOTCH2 proteins, we have identified potential therapeutic targets for patients with rare bone diseases as well as much more widespread age-related osteoporosis,” said Inuzuka.
Learn more: Reversing severe bone loss
The Latest on: Bone loss
- CHLA Receives $2.3M to Study Bone Loss Tied to Cerebral Palsy on September 18, 2018 at 12:01 pm
A researcher at Children’s Hospital Los Angeles has received a $2.3 million federal grant to study bone loss associated with cerebral palsy, the hospital announced Sept. 18. The Eunice Kennedy ... […]
- Investigator at CHLA to study bone loss associated with cerebral palsy on September 13, 2018 at 7:15 am
Gait analysis being performed in Motion Analysis Lab at CHLA. Credit: Children's Hospital Los Angeles Cerebral palsy (CP) is the most common physical disability originating in childhood. […]
- Antioxidant Defender Can Protect Against Bone and Brain Disorders on September 13, 2018 at 6:22 am
The researchers also discovered that ANP32A deficiency was linked to osteopenia (bone loss) and a neurological disease similar to ataxia-telangiectasia (A-T) in mice, and that these disorders could al... […]
- How Do Workouts Affect Your Bone Health? on September 10, 2018 at 2:22 am
To uncover the best way to maintain bone health, the researchers investigated a group of people who only worked on weight loss, another worked on weight loss and resistance exercise, and the third did ... […]
- Bone Loss Isn't Just for Women—Here's How to Tell If You Have It, Too on August 27, 2018 at 12:00 pm
When you hear the term “osteopenia,” you’re probably wondering, “Does that have anything to do with osteoporosis? Don’t only old people get that?” The truth is that yes, osteoporosis is most common am... […]
- Can community exercise prevent bone loss from weight loss in older adults? on August 8, 2018 at 1:20 am
In a Journal of Bone and Mineral Research study of older adults with obesity who were cutting calories, an intervention that incorporated resistance training, aerobic training, or neither did not prev... […]
- Effect of Mediterranean Diet Plus Vitamin D3 on Bone Density in Osteoporosis on July 30, 2018 at 11:49 pm
in individuals with a BMD within the normal age-related range but did significantly reduce the rate of bone loss in the femoral neck in patients with osteoporosis, according to new findings published ... […]
- Probiotic shows reduction in bone loss in older women on July 14, 2018 at 11:41 am
Researchers have used a probiotic to determine whether there is a reduction in the rate of bone related mineral density loss in older women. The results are encouraging, suggesting further study is wo... […]
- Decoded: What causes bone loss on March 10, 2018 at 3:48 am
New York, March 10 (IANS) The lack of a protein key to the control of inflammation may be responsible for rapid and severe bone loss, finds a study that could lead to improved care for older adults at ... […]
- What causes bone loss in elderly on September 24, 2017 at 1:51 am
New York, Sep 24 (IANS) Researchers have identified a mechanism that leads to bone loss in older adults, an advance that may help develop therapeutics to treat the age-associated bone loss condition. ... […]
via Google News and Bing News